Study Stopped
Company decision
A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHED
1 other identifier
observational
N/A
1 country
1
Brief Summary
The proposed natural history study will enroll male patients with a diagnosis of XLHED, female carriers of XLHED and healthy volunteers. The study protocol will include collection of XLHED questionnaires and clinical outcomes using minimally invasive technologies. Data will be collected both retrospectively and prospectively. Clinical outcome assessments will be performed at the NFED Family Conference on July 11-12, 2019. Study participants will be able to complete XLHED questionnaires electronically ahead of the conference.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
April 11, 2019
CompletedStudy Start
First participant enrolled
June 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedJuly 2, 2019
June 1, 2019
2 months
April 10, 2019
June 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The volume of sweat from a pilocarpine-induced sweat test
Day 1
Study Arms (2)
XLHED Patients
Healthy Controls
Eligibility Criteria
Males with XLHED and female carriers of XLHED Male and female healthy volunteers
You may qualify if:
- Informed Consent
- Males with XLHED, female carriers of XLHED and healthy volunteers
You may not qualify if:
- Treatment with an investigational study drug for XLHED
- Any major medical problems that would prevent her/him from participating in this study
- Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists (Examples: Urecholine, Salagen, Pilocar, and Provocholine)
- Pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chicago Marriott Lincolnshire Resort
Lincolnshire, Illinois, 60069, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorothy K Grange, MD
Washington University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2019
First Posted
April 11, 2019
Study Start
June 28, 2019
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
July 2, 2019
Record last verified: 2019-06